scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051843441 |
P356 | DOI | 10.1186/S40478-015-0209-Z |
P932 | PMC publication ID | 4489160 |
P698 | PubMed publication ID | 26001591 |
P5875 | ResearchGate publication ID | 277937956 |
P50 | author | Richard John Kryscio | Q102165574 |
Adam D Bachstetter | Q56441597 | ||
Erin L Abner | Q60665975 | ||
Frederick A. Schmitt | Q64778804 | ||
Peter T Nelson | Q90936675 | ||
Linda J Van Eldik | Q99563495 | ||
P2093 | author name string | Ela Patel | |
Eseosa T Ighodaro | |||
Janna H Neltner | |||
Scott J Webster | |||
P2860 | cites work | TREM2 Variants in Alzheimer's Disease | Q22250873 |
Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
Microglial pathology | Q26992285 | ||
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease | Q26996741 | ||
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
Microglia-specific localisation of a novel calcium binding protein, Iba1 | Q28273977 | ||
Identification of a unique TGF-β-dependent molecular and functional signature in microglia | Q28303557 | ||
Physiology of microglia | Q29547414 | ||
ATP mediates rapid microglial response to local brain injury in vivo | Q29547872 | ||
Rod microglia: a morphological definition | Q33618424 | ||
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons | Q33828911 | ||
Microglial senescence: does the brain's immune system have an expiration date? | Q34550017 | ||
Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study | Q34738383 | ||
Hippocampal sclerosis in advanced age: clinical and pathological features. | Q34992164 | ||
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology | Q36131008 | ||
Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat. | Q36372703 | ||
Rod microglia: elongation, alignment, and coupling to form trains across the somatosensory cortex after experimental diffuse brain injury. | Q36478500 | ||
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature | Q36575903 | ||
Neuroinflammatory phenotype in early Alzheimer's disease | Q36629135 | ||
The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury. | Q36887359 | ||
Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta | Q36996975 | ||
CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. | Q37093860 | ||
Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex | Q37195038 | ||
Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease | Q37331433 | ||
The microglial sensome revealed by direct RNA sequencing | Q37341692 | ||
Morphometric characterization of microglial phenotypes in human cerebral cortex | Q37532369 | ||
Microglial dysfunction in brain aging and Alzheimer's disease | Q37678533 | ||
Changing face of microglia | Q37807203 | ||
Microglial activation in the injured and healthy brain: what are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology | Q38028703 | ||
Review: activation patterns of microglia and their identification in the human brain. | Q38068503 | ||
The human side of microglia | Q38175607 | ||
New stereological methods for counting neurons | Q40843719 | ||
Surface expression and rapid internalization of macrosialin (mouse CD68) on elicited mouse peritoneal macrophages. | Q40904050 | ||
Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology | Q42276637 | ||
Phagocytosis stimulates alternative glycosylation of macrosialin (mouse CD68), a macrophage-specific endosomal protein | Q42993102 | ||
Dystrophic microglia in the aging human brain | Q48090856 | ||
Fusion of microglia with pyramidal neurons after retroviral infection. | Q48380856 | ||
Microglial pathology in Down syndrome | Q48946346 | ||
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. | Q52059797 | ||
Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. | Q53392859 | ||
The unbiased estimation of number and sizes of arbitrary particles using the disector | Q71397942 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
dementia | Q83030 | ||
microglia | Q1622829 | ||
hippocampal sclerosis | Q4421929 | ||
dementia with Lewy bodies | Q101245788 | ||
P304 | page(s) | 32 | |
P577 | publication date | 2015-05-23 | |
P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
P1476 | title | Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging | |
P478 | volume | 3 |
Q38841003 | "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). |
Q48523519 | Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and Nasu-Hakola disease: lesion staging and dynamic changes of axons and microglial subsets |
Q64968111 | Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease |
Q42364364 | CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease. |
Q38697830 | Carnitine/Organic Cation Transporter OCTN1 Negatively Regulates Activation in Murine Cultured Microglial Cells. |
Q47905080 | Changes in neocortical and hippocampal microglial cells during hibernation. |
Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
Q93170074 | Developmental roles of microglia: A window into mechanisms of disease |
Q90442086 | Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques |
Q45873297 | Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration |
Q55127801 | Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. |
Q100763996 | Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome |
Q92546313 | Dystrophic microglia in late-onset Alzheimer's disease |
Q58605846 | Early microglial activation and peripheral inflammation in dementia with Lewy bodies |
Q55027556 | Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study. |
Q47728916 | Hippocampal sclerosis, hippocampal neuron loss patterns and Tdp-43 in the aged population. |
Q36198753 | Human gut microbiota: the links with dementia development |
Q48627278 | Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer's disease |
Q91660737 | Intersection of pathological tau and microglia at the synapse |
Q41605528 | Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation |
Q57030260 | L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer's Disease |
Q64385732 | Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. |
Q61446941 | Loss of Par1b/MARK2 primes microglia during brain development and enhances their sensitivity to injury |
Q64111160 | MIC-MAC: An automated pipeline for high-throughput characterization and classification of three-dimensional microglia morphologies in mouse and human postmortem brain samples |
Q47920956 | Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review |
Q90705375 | Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees |
Q91137024 | Microglia heterogeneity along a spatio-temporal axis: More questions than answers |
Q92862117 | Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations |
Q48424552 | Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease. |
Q64791367 | Microglial cell activation and senescence are characteristic of the pathology FXTAS |
Q26800212 | Microglial cell dysregulation in brain aging and neurodegeneration |
Q37374408 | Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. |
Q58804178 | Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity |
Q38690794 | Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem Cells |
Q64920077 | Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies |
Q38962283 | Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets |
Q98196645 | Neuroinflammation in dementia with Lewy bodies: a human post-mortem study |
Q92580591 | Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy |
Q38915426 | Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi |
Q48020146 | Pathology and hippocampal atrophy in Alzheimer's disease |
Q34681725 | Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration |
Q89851154 | Progressive long-term spatial memory loss following repeat concussive and subconcussive brain injury in mice, associated with dorsal hippocampal neuron loss, microglial phenotype shift, and vascular abnormalities |
Q53397355 | Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia. |
Q97548304 | Quantitative immunohistochemical analysis of myeloid cell marker expression in human cortex captures microglia heterogeneity with anatomical context |
Q92554764 | Rapid neuroinflammatory changes in human acute intracerebral hemorrhage |
Q36376140 | Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration |
Q38764818 | Rod-shaped microglia morphology is associated with aging in 2 human autopsy series |
Q92794075 | Shifting equilibriums in Alzheimer's disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis |
Q49468860 | Status Epilepticus Triggers Time-Dependent Alterations in Microglia Abundance and Morphological Phenotypes in the Hippocampus |
Q64899660 | Studying Heterotypic Cell⁻Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration. |
Q26744219 | Targeting innate immunity for neurodegenerative disorders of the central nervous system |
Q39243339 | Tau Spread, Apolipoprotein E, Inflammation, and More: Rapidly Evolving Basic Science in Alzheimer Disease |
Q98292287 | The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology |
Q36334069 | The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain |
Q55071445 | The contribution of microglia to early synaptic compensatory responses that precede β-amyloid-induced neuronal death. |
Q28066693 | The microbiome: A key regulator of stress and neuroinflammation |
Q27313529 | Toll-Like Receptor 4 Deficiency Impairs Motor Coordination |
Q38435692 | Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies |
Q46001503 | iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. |
Search more.